The large number of emerging antibody-drug conjugates (ADCs) for cancer therapy has resulted in a significant market ‘boom’, garnering worldwide attention. Despite ADCs presenting huge challenges to researchers, particularly regarding the identification of a suitable combination of antibody, linker,...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!